HIGHLIGHTS
- who: Elisaveta Skverchinskaya and colleagues from the Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Laboratory of Renewable Energy Sources, Alferov University, Saint-Petersburg, Russia have published the Article: Anticancer Drugs Paclitaxel, Carboplatin, Doxorubicin, and Cyclophosphamide Alter the Biophysical Characteristics of Red Blood Cells, In Vitro, in the Journal: (JOURNAL)
- what: The aim of this study is to evaluate the functional status of RBCs exposed to mono and combinations of widely used commercial pharmaceutical CT with different action mechanisms: cyclophosphamide and in vitro. Using laser diffraction flow cytometry and confocal . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.